Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Congresses
This is the logo of the provider
London ,  UK 7 - 10 October 2026

Academy for Sickle Cell and Thalassaemia (ASCAT 2026)

Presentation schedule and materials
Wednesday, 07 October 2026
16:30  - 18:00
GMT
126
ORAL PRESENTATION
Etavopivat reduces transfusion in adults and adolescents with transfusion-dependent α- or β-thalassaemia: Phase 2 results
Ashutosh Lal1*, Saranya Veluswamy2, Melanie Kirby-Allen3, Yves Dominique Pastore4, Janet L. Kwiatkowski5, E. Leila Jerome Clay6, Olga Polyanskaya7, Navid Nedjatian8, Ali T. Taher9
MATERIALS AVAILABLE
nn-ascat-26-oral-gladiolus-open-label
Slide
Thursday, 08 October 2026
10:30  - 11:30
GMT
P 09.01
POSTER
ASCRIBE: Real-world burden and healthcare resource utilisation of sickle cell disease in the United Kingdom
Kofi A. Anie1,2*, Kim Brown3, Johan Cherian3, Iwan Armstrong4, Sophie Lai4, Martin Besser5
MATERIALS AVAILABLE
real-world-burden
Poster
10:30  - 11:30
GMT
P08.05
POSTER
Treatment patterns, adherence and satisfaction among PwSCD in Bahrain: Data from ASCRIBE study
Rohan Kolla1, Shashidhar Rao1, Johan Cherian1, Rabiyah Sahar2
MATERIALS AVAILABLE
ascribe-study
Poster
10:30  - 11:30
GMT
P08.06
POSTER
Treatment patterns, adherence and patient satisfaction in SCD in UAE: Findings from ASCRIBE study
Shashidhar Rao1, Rohan Kolla1, Navid Nedjatian1, Rabiyah Sahar2
MATERIALS AVAILABLE
scd-in-uae
Poster
14:30  - 16:30
GMT
115
ORAL PRESENTATION
Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassaemia: results from the open-label phase 2 gladiolus study
Sujit Sheth1*, Kevin H.M. Kuo2,3, Theodosia A. Kalfa4, D. Mark Layton5, Perla Eleftheriou6, Anastasios Giakoumis7, Olga Polyanskaya8, Navid Nedjatian9 and Ashutosh Lal10
MATERIALS AVAILABLE
nn-ascat-26-oral-hemoglobin-levels
Slide
16:30  - 17:00
GMT
113
ORAL PRESENTATION
Social Determinants of Health and Economic Burden in Commercially Insured US Adults with Sickle Cell Disease
Elnara Fazio-Eynullayeva1; Vamshi Ruthwik Anupindi2; Queenie Paltanwale2; Aimee Near2; E. Leila Jerome Clay1; Tarun Aurora3
MATERIALS AVAILABLE
thursday-george-thomas-room-3_09-aurora
Slide
Friday, 09 October 2026
09:00  - 11:15
GMT
171
ORAL PRESENTATION
Transfusion-dependent SCD: management challenges and emerging phase 2 evidence for etavopivat
Beng Richard Fuh1*, Mona Hamdy2, Saranya Veluswamy3, Kevin H.M. Kuo4,5, Sunil Navani6, Olga Polyanskaya7, Navid Nedjatian8, Ashutosh Lal9
MATERIALS AVAILABLE
nn-ascat-26-phase-2-evidence
Slide
Keywords
Sickle Cell Disease
Thalassemia
ASCAT